Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer
- Conditions
- Prostate CancerProstate Adenocarcinoma
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Profound Medical Inc.
- Target Recruit Count
- 201
- Registration Number
- NCT05027477
- Locations
- 🇺🇸
Arizona State Urological Institute, Chandler, Arizona, United States
🇺🇸East Valley Urological Center, Mesa, Arizona, United States
🇺🇸Investigate MD, Scottsdale, Arizona, United States
Customized TULSA-PRO Ablation Registry
- Conditions
- Benign Prostatic HyperplasiaProstate CancerProstate Adenocarcinoma
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Profound Medical Inc.
- Target Recruit Count
- 1000
- Registration Number
- NCT05001477
- Locations
- 🇺🇸
RadNet's Liberty Pacific West Hills Facility, West Hills, California, United States
🇺🇸Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸Wellspan Health, York, Pennsylvania, United States
Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2016-05-09
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Profound Medical Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT02766543
- Locations
- 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇺🇸Yale Cancer Centre, New Haven, Connecticut, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2012-09-18
- Last Posted Date
- 2020-02-11
- Lead Sponsor
- Profound Medical Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01686958
- Locations
- 🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States
🇨🇦London Health Science Centre, London, Ontario, Canada
🇩🇪German Cancer Research Center (DKFZ), Heidelberg, Germany